Drug-mediated inhibition of Fli-1 for the treatment of leukemia

Blood Cancer Journal

Volumn 2, Issue 1, 2012, Pages

  Li, Y J ^a   Zhao, X ^a   Vecchiarelli Federico, L M ^a,b   Li, Y ^a   Datti, A ^c,d   Cheng, Y ^e   Ben David, Y ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d UNIVERSITY OF PERUGIA   (Italy)

^e KUNMING INSTITUTE OF BOTANY   (China)

Author keywords

Drug inhibition; Erythroleukemia; Fli 1

Indexed keywords

ALEXIDINE; ANISOMYCIN; ANTILEUKEMIC AGENT; CALCIMYCIN; CALCIUM IONOPHORE; CAMPTOTHECIN; CARDENOLIDE; CONVALATOXIN; CYCLOHEXIMIDE; CYMARIN; DACTINOMYCIN; DIGITOXIN; DIHYDROOUABAIN; DNA TOPOISOMERASE INHIBITOR; EMETINE; ETOPOSIDE; FUNCTIONAL GROUP; GOSSYPOL ACETIC ACID; LANATOSIDE C; MESSENGER RNA; OLIGOMYCIN; PERUVOSIDE; PROSCILLARIDIN; PROTEIN SYNTHESIS INHIBITOR; PROTEIN TYROSINE PHOSPHATASE SHP 1; STROPHANTHIDIN; THAPSIGARGIN; TRANSCRIPTION FACTOR FLI 1; TRANSCRIPTION FACTOR GATA 1; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; DNA BINDING; DRUG SCREENING; DRUG TARGETING; ERYTHROLEUKEMIA; HUMAN; HUMAN CELL; INHIBITION KINETICS; LEUKEMIA; LEUKEMIA CELL; LEUKEMOGENESIS; MITOSIS INHIBITION; NONHUMAN; ONCOGENE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

EID: 84863898210     PISSN: None     EISSN: 20445385     Source Type: Journal    
DOI: 10.1038/bcj.2011.52     Document Type: Article

References (29)

1. Ben-David Y, Giddens EB, Bernstein A. Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus. Proc Natl Acad Sci USA 1990; 87: 1332-1336.
2. Ben-David Y, Giddens EG, Letwin K, Bernstein A. Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. Genes Dev 1991; 5: 908-918. (Pubitemid 21906006)
3. Tamir A, Howard J, Higgins RR, Li YJ, Berger L, Zacksenhaus E et al. Fli-1, an Ets-related transcription factor, regulates erythropoietin-induced erythroid proliferation and differentiation: evidence for direct transcriptional repression of the Rb gene during differentiation. Mol Cell Biol 1999; 19: 4452-4464. (Pubitemid 29242019)
4. Zochodne B, Truong AH, Stetler K, Higgins RR, Howard J, Dumont D et al. Epo regulates erythroid proliferation and differentiation through distinct signaling pathways: implication for erythropoiesis and Friend virus-induced erythroleukemia. Oncogene 2000; 19: 2296-2304. (Pubitemid 30307205)
5. Bergeron D, Poliquin L, Kozak CA, Rassart E. Identification of a common viral integration region in Cas-Br-E murine leukemia virus-induced non-T, non-B cell lymphomas. J Virol 1991; 65: 7-15.
6. Delattre O, Zucman J, Plougastel B, Desmaze C, Melot T, Peter M et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 1992; 359: 162-165.
7. Kwiatkowski BA, Bastian LS, Bauer TR, Tsai S, Zielinska-Kwiatkowska AG, Hickstein DD. The ets family member Tel binds to the Fli-1 oncoprotein and inhibits its transcriptional activity. J Biol Chem 1998; 273: 17525-17530. (Pubitemid 28355086)
8. Mhawech-Fauceglia P, Herrmann F, Bshara W, Odunsi K, Terracciano L, Sauter G et al. FLI-1 Expression in 4323 malignant and benign tumours: a multiple tumour tissue microarray analysis using polyclonal antibody. J Clin Pathol 2006; 60: 694-700. (Pubitemid 46975228)
9. Cui JW, Vecchiarelli-Federico LM, Li YJ, Wang GJ, Ben-David Y. Continuous Fli-1 expression plays an essential role in the proliferation and survival of F-MuLVinduced erythroleukemia and human erythroleukemia. Leukemia 2009; 23: 1311-1319.
10. Juban G, Giraud G, Guyot B, Belin S, Diaz JJ, Starck J et al. Spi-1 and Fli-1 directly activate common target genes involved in ribosome biogenesis in Friend erythroleukemic cells. Mol Cell Biol 2009; 29: 2852-2864.
11. Lakhanpal GK, Vecchiarelli-Federico LM, Li YJ, Cui JW, Bailey ML, Spaner DE et al. The inositol phosphatase SHIP-1 is negatively regulated by Fli-1 and its loss accelerates leukemogenesis. Blood 2010; 116: 428-436.
12. May WA, Gishizky ML, Lessnick SL, Lunsford LB, Lewis BC, Delattre O et al. Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. Proc Natl Acad Sci USA 1993; 90: 5752-5756. (Pubitemid 23176240)
13. Zhang JH, Chung TD, Oldenburg KR. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999; 4: 67-73. (Pubitemid 29278954)
14. Brideau C, Gunter B, Pikounis B, Liaw A. Improved statistical methods for hit selection in high-throughput screening. J Biomol Screen 2003; 8: 634-647.
15. Prassas I, Paliouras M, Datti A, Diamandis EP. High-throughput screening identifies cardiac glycosides as potent inhibitors of human tissue kallikrein expression: implications for cancer therapies. Clin Cancer Res 2008; 14: 5778-5784.
16. Sparatore B, Pessino A, Patrone M, Passalacqua M, Melloni E, Pontremoli S. Changes in calcium influx affect the differentiation of murine erythroleukaemia cells. Biochem J 1995; 305 (Pt 1): 285-290.
17. Priel E, Aflalo E, Chechelnitsky G, Benharroch D, Aboud M, Segal S. Inhibition of retrovirus-induced disease in mice by camptothecin. J Virol 1993; 67: 3624-3629. (Pubitemid 23143744)
18. Bhatia S, Krailo MD, Chen Z, Burden L, Askin FB, Dickman PS et al. Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: a report from the Children's Oncology Group. Blood 2007; 109: 46-51. (Pubitemid 46053041)
19. Perne A, Muellner MK, Steinrueck M, Craig-Mueller N, Mayerhofer J, Schwarzinger I et al. Cardiac glycosides induce cell death in human cells by inhibiting general protein synthesis. PLoS ONE 2009; 4: e8292.
20. Moreau-Gachelin F, Tavitian A, Tambourin P. Spi-1 is a putative oncogene in virally induced murine erythroleukaemias. Nature 1988; 331: 277-280. (Pubitemid 18040597)
21. Zhang XK, Watson DK. The FLI-1 transcription factor is a short-lived phosphoprotein in T cells. J Biochem 2005; 137: 297-302. (Pubitemid 40628435)
22. Asano Y, Trojanowska M. Phosphorylation of Fli1 at threonine 312 by protein kinase C delta promotes its interaction with p300/CREB-binding proteinassociated factor and subsequent acetylation in response to transforming growth factor beta. Mol Cell Biol 2009; 29: 1882-1894.
23. Howard JC, Ung Y, Adachi D, Ben-David Y. p53-independent tumor growth and in vitro cell survival for F-MuLV-induced erythroleukemias. Cell Growth Differ 1996; 7: 1651-1660. (Pubitemid 26415161)
24. Mager D, Bernstein A. The program of Friend cell erythroid differentiation: early changes in Na+/K+ ATPase function. J Supramol Struct 1978; 8: 431-438. (Pubitemid 9053804)
25. Bernstein A, Hunt DM, Crichley V, Mak TW. Induction by ouabain of hemoglobin synthesis in cultured Friend erythroleukemic cells. Cell 1976; 9: 375-381. (Pubitemid 8003664)
26. Rasheed ZA, Rubin EH. Mechanisms of resistance to topoisomerase I-targeting drugs. Oncogene 2003; 22: 7296-7304. (Pubitemid 37487161)
27. Winnicka K, Bielawski K, Bielawska A. Cardiac glycosides in cancer research and cancer therapy. Acta Pol Pharm 2006; 63: 109-115. (Pubitemid 351359766)
28. Lawrence TS. Reduction of doxorubicin cytotoxicity by ouabain: correlation with topoisomerase-induced DNA strand breakage in human and hamster cells. Cancer Res 1988; 48: 725-730. (Pubitemid 18056549)
29. Levenson R, Housman D, Cantley L. Amiloride inhibits murine erythroleukemia cell differentiation: evidence for a Ca2+ requirement for commitment. Proc Natl Acad Sci USA 1980; 77: 5948-5952. (Pubitemid 11211238)